Emmanouil V Dermitzakis
Overview
Explore the profile of Emmanouil V Dermitzakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vikelis M, Rikos D, Argyriou A, Dermitzakis E, Andreou A, Russo A
Expert Rev Neurother
. 2025 Jan;
:1-16.
PMID: 39884968
Introduction: When a first anti-CGRP monoclonal antibody (anti-CGRP mAb) fails, switching to a different anti-CGRP mAb is an option often considered, despite the fact that this approach is not yet...
2.
Dermitzakis E, Rikos D, Vikelis M, Xiromerisiou G, Zisopoulou S, Rallis D, et al.
Brain Sci
. 2025 Jan;
14(12.
PMID: 39766367
The present open-label multicenter pilot study sought to prospectively evaluate the efficacy and safety of rimegepant in treating migraine attacks. The primary endpoint was pain freedom at two hours post-dose,...
3.
Argyriou A, Dermitzakis E, Xiromerisiou G, Rikos D, Rallis D, Soldatos P, et al.
Expert Rev Neurother
. 2024 Sep;
24(11):1119-1126.
PMID: 39279446
Objective: This post-hoc analysis of data extracted from a prospective study aimed to explore for the first time if the efficacy of fremanezumab in preventing difficult-to-treat migraine, according to ICHD-III,...
4.
Vikelis M, Rikos D, Argyriou A, Papachristou P, Rallis D, Karapanayiotides T, et al.
Expert Rev Neurother
. 2024 Jun;
24(8):815-826.
PMID: 38870024
Background: To identify the preferences and perceptions of migraine patients for acute and preventive treatment options and to investigate which treatment outcomes are the most important. Design And Methods: The...
5.
Dermitzakis E, Argyriou A, Bilias K, Barmpa E, Liapi S, Rikos D, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792309
The Greek Society of Migraine and Headache Patients conducted its third in-line population web-based survey in 2023 to ascertain if the burden of the disease and the patients' satisfaction with...
6.
Rikos D, Vikelis M, Dermitzakis E, Soldatos P, Rallis D, Rudolf J, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610729
Phase II/III randomized clinical trials (RCTs) are vulnerable to many types of bias beyond randomization. Insights into the reporting quality of RCTs involving migraine patients treated with monoclonal antibodies targeting...
7.
Argyriou A, Dermitzakis E, Rikos D, Xiromerisiou G, Soldatos P, Litsardopoulos P, et al.
Toxins (Basel)
. 2024 Feb;
16(2).
PMID: 38393184
Background: We primarily aimed to ascertain whether treatment with OnabotulinumtoxinA (BoNTA) might influence the extent of the interictal burden and cutaneous allodynia in patients with chronic migraine (CM). Methods: Seventy...
8.
Dermitzakis E, Vikelis M, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, et al.
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256516
To investigate whether the incidence of triggers, prodromal symptoms, hypersensitivity symptoms accompanying headache and responses to triptans were modified during a continuous 9-month fremanezumab therapy for migraine prophylaxis. We studied...
9.
Xiromerisiou G, Lampropoulos I, Dermitzakis E, Vikelis M, Marogianni C, Mysiris D, et al.
Toxins (Basel)
. 2023 Sep;
15(9).
PMID: 37755965
We sought to assess the efficacy of combining onabotulinumtoxinA (BoNTA) as add-on therapy to carbamazepine or oxcarbazepine in treatment-refractory patients with trigeminal neuralgia (TGN) who failed to respond (less than...
10.
Papasavva M, Vikelis M, Siokas V, Katsarou M, Dermitzakis E, Raptis A, et al.
Neurol Int
. 2023 Sep;
15(3):1117-1128.
PMID: 37755360
Migraine is a common primary headache disorder with both environmental and genetic inputs. Cumulative evidence indicates an association between vitamin D and headache. Unravelling the precise role of vitamin D...